Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.54 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.53 |
| ▸ | FAAH | O00519 | 5/20 | 0.53 |
| ▸ | NAAA | Q02083 | 1/20 | 0.51 |
| ▸ | SLC6A5 | Q9Y345 | 2/20 | 0.51 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.50 |
| ▸ | TLR2 | O60603 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.49 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.46 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.46 |
| ▸ | ALB | P02768 | 1/20 | 0.46 |
| ▸ | GLP1R | P43220 | 1/20 | 0.45 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15084766 | 0.89 | NOD1 (0.63) | CASP2NOD1FAAHNAAASLC6A5 | |
| SCHEMBL24796256 | 0.89 | CASP2 (0.54) | CASP2NOD1FAAHNAAASLC6A5 | |
| SCHEMBL24390488 | 0.87 | CASP2 (0.53) | CASP2NOD1FAAHNAAASLC6A5 | |
| SCHEMBL24390489 | 0.87 | CASP2 (0.53) | CASP2NOD1FAAHNAAASLC6A5 | |
| SCHEMBL20471131 | 0.86 | ALB (0.61) | CASP2NOD1FAAHNAAASLC6A5 | |
| SCHEMBL21389124 | 0.86 | CASP2 (0.51) | CASP2NOD1FAAHNAAASLC6A5 | |
| SCHEMBL22386556 | 0.84 | NAAA (0.61) | CASP2NOD1FAAHNAAADNM1 | |
| SCHEMBL22646981 | 0.82 | NOD1 (0.59) | CASP2NOD1FAAHNAAASLC6A5 | |
| SCHEMBL13120985 | 0.82 | CASP2 (0.57) | CASP2NOD1FAAHNAAASLC6A5 | |
| SCHEMBL25878486 | 0.82 | CASP2 (0.57) | CASP2NOD1FAAHNAAASLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023139106-A2 | LONG-ACTING GIPR ANTAGONISTS | NOVO NORDISK A/S (DK) | 2023-07-27 | — | — | WO | disclosed |